Bimaplan
+41%
est. 2Y upside i
Affordable insurance for the next billion Indians
Rank
#2001
Sector
Insurtech, Fintech
Est. Liquidity
~6Y
Data Quality
Data: LowBimaplan shows genuine traction — $8.4M revenue growing 87% YoY is exceptional for a 42-person Pre-Series A insurtech — but the 2-year equity horizon is far too early for any liquidity, and the undisclosed current valuation makes it impossible to verify the grant price.
Last updated: May 14, 2026
Bimaplan sustains 60-70% revenue growth through 2027, reaching ~$20-22M revenue, and closes a Series A at $90-100M (~5x revenue). After ~22% dilution from the new round, common equity appreciates roughly 2x-2.5x in paper value within 2 years.
Growth moderates to 40-50% as B2B2C partnerships scale, reaching ~$14-16M revenue, and the company closes a Series A at $50-60M (~3.5x revenue). After dilution, common equity appreciates ~40% on paper with no liquidity event in the 2-year window.
Growth slows below 25% due to competitive pressure from Digit Insurance and Acko or IRDAI regulatory friction; a bridge or down/flat round severely dilutes common stockholders, eroding 70-80% of paper equity value.
Preference Stack Risk
highFunding Intensity
30%$6M total liquidation preference against an estimated ~$20M current valuation means roughly 30% of enterprise value must clear preferred shareholders before common stockholders receive any proceeds.
Dilution Risk
highAt Pre-Series A stage, 2-4 additional funding rounds are likely before any liquidity event, each carrying 15-25% dilution; cumulative dilution of 40-60% from current ownership percentage is probable.
Secondary Liquidity
noneNo secondary market exists for a 42-person Pre-Series A Indian insurtech; equity is fully illiquid until an acquisition or IPO, realistically 5-7+ years away.
Questions to Ask at the Interview
Strategic questions based on Bimaplan's data — designed to show you've done your homework.
- 1
“What is the current post-money valuation and total liquidation preference stack — are investor shares participating or non-participating preferred, and is there a liquidation preference multiplier?”
- 2
“What is the revenue split between distribution commissions and any risk-sharing arrangements, and what is net revenue retention across your top B2B2C distribution partners?”
- 3
“What is the vesting schedule and cliff for the equity grant, and has the board approved a current fair-market-value (ESOP) valuation in the last 12 months?”
Community
Valuation Sentiment
Our model estimates +41% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.